TSPAN8 and Patent ductus arteriosus: Deep sequencing revealed altered mRNA and miRNA expression profiles of non-CIC following PDA tumor cells derived-EVs treatment, phenotypically translating to Cd44v6 and Tspan8 concerted non-CIC activation, apoptosis resistance, EMT and higher motility.